| Note |
Presence of mind in antianxiety therapy. Centrax (prazepam) offers low potential for sedation. This can be a special attribute in an antianxiety agent. Clouded thinking has no place in the work environment, where psychomotor precision is often important. Moreover, altered mentation may pose additional problems for patients at home or on busy streets, where clearness of mind is just as essential. Noticeable dose-related transient peaks of drug effect are infrequent with centrax, the antianxiety agent that offers these advantages: drowsiness is infrequent (6.8%) at recommended doses. A psychomotor performance study in a normal population showed no statistical significant impairment with prazepam at recommended doses. Changes in mentation are minimized, light headedness is infrequent (6.8%), and signs of altered states of mind are rare. |
